Over expression of glycolytic gene DLAT, which promoted glycolysis but suppressed acetyl-CoA production and enhanced the malignancy of non-small cell lung cancer (NSCLC) cells. This evidence concerns the gene DLAT and non-small cell lung carcinoma.